Molecular Responses at 3 and 6 Months Predict Outcomes in Patients With Chronic Myeloid Leukemia in Chronic Phase Treated With Front-line Imatinib: Taiwan CML Study Group
Titel:
Molecular Responses at 3 and 6 Months Predict Outcomes in Patients With Chronic Myeloid Leukemia in Chronic Phase Treated With Front-line Imatinib: Taiwan CML Study Group